您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
CEL / Cell Imaging

Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 594

Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 594

Product Details Host Species:GoatReactivity:RabbitConcentration:1 mg/mL Clonality:PolyclonalIsotype:IgGConjugate:Alexa Fluor 594 Formulation:Liquid in PBS containing 50% glycerol, 1% BSA and 0.05% PC3

生物试剂 供应商 艾碧维 ↗ 型号 AWS0006 更新 2026-10-31
参考价格区间
¥80
含税参考价,实际以配置与渠道报价为准
本条目供应商 艾碧维原厂 498个条目 进入企业主页

01产品图片

02产品简介

Product Details Host Species:GoatReactivity:RabbitConcentration:1 mg/mL Clonality:PolyclonalIsotype:IgGConjugate:Alexa Fluor 594 Formulation:Liquid in PBS containing 50% glycerol, 1% BSA and 0.05% PC3

03产品介绍

Product Details Host Species:GoatReactivity:RabbitConcentration:1 mg/mL Clonality:PolyclonalIsotype:IgGConjugate:Alexa Fluor 594 Formulation:Liquid in PBS containing 50% glycerol, 1% BSA and 0.05% PC300. Purification:Affinity-chromatography Storage:-20°C,store in dark,1 year Applications IF 1:100-1:1000 FCM 1:100-1:1000 Information Based on immunoelectrophoresis and/or ELISA, the antibody reacts with whole molecule rabbit IgG. It also reacts with the light chains of other rabbit immunoglobulins. No antibody was detected against non-immunoglobulin serum proteins. The antibody may cross-react with immunoglobulins from other species.

Product images Fig: Fluorescence immunohistochemical analysis of Mouse-preoptic area tissue (Formalin/PFA-fixed paraffin-embedded sections). Goat Anti-RABBIT IgG H&L (iFluor™ 594, AWS0006) was used as the secondary antibody at 1/200 dilution for 60 minutes at 37 ℃.DAPI (blue, AWC0291) was used as a nuclear counter stain. Image acquisition was performed with Slide Scanner. Fig: Fluorescence immunohistochemical analysis of Mouse-preoptic area tissue (Formalin/PFA-fixed paraffin-embedded sections). Goat Anti-RABBIT IgG H&L (iFluor™ 594, AWS0006) was used as the secondary antibody at 1/200 dilution for 60 minutes at 37 ℃.DAPI (blue, AWC0291) was used as a nuclear counter stain. Image acquisition was performed with Slide Scanner.

认真做好每一个抗体, 每一个抗体都经过反复验证!

Target identification in natural products plays a critical role in the development of innovative drugs. Bufalin, a compound derived from traditional medicines, has shown promising anti-cancer activity; however, its precise molecular mechanism of action remains unclear. Here, we employ artificial intelligence, molecular docking, and molecular dynamics simulations to elucidate the molecular mechanism of Bufalin. Using an integrated multi-predictive strategy, we identify CYP17A1, ESR1, mTOR, AR, and PRKCD as the potential targets of Bufalin. Subsequent validation via surface plasmon resonance, biotin pulldown, and thermal shift assays confirms Bufalin’s direct binding to ESR1, which encodes estrogen receptor alpha (ERα). Molecular docking analyses pinpoint Bufalin’s selective interaction with Arg394 on ERα. Molecular dynamic simulations further show that Bufalin acts as a molecular glue, enhancing the interaction between ERα and the E3 ligase STUB1, thereby promoting proteasomal degradation of ERα. Given the therapeutic potential of ERα degradation in overcoming endocrine resistance, we investigate the inhibitory effect of Bufalin on endocrine-resistant models and prove Bufalin reverses Tamoxifen resistance in vitro, in vivo, and in patient-derived breast cancer organoids from tamoxifen-relapsed cases. Collectively, our findings indicate that Bufalin functions as a molecular glue to degrade ERα, offering a potential therapeutic strategy for reversing Tamoxifen resistance.

Authors:Jiang Shilong, Liu Keyi, Jiang Ting, Li Hui, Wei Xiao, Wan Xiaoya, Zhong Changxin, Gong Rong, Chen Zonglin, Zou Chan, Zhang Qing, Cheng Yan, Cao Dongsheng

Identifying novel therapeutic targets and drugs is crucial for treating triple-negative breast cancer (TNBC). Bufalin, a key active ingredient of the traditional Chinese medicine HuaChansu , has been employed in tumor therapy. Here, SPR-LC-MS/MS is employed to characterize the targets of Bufalin and found that serine/threonine kinase 33 (STK33) possesses a strong binding affinity to Bufalin. Combining molecular docking, SPR analysis, and Biotin-pulldown analysis, it is demonstrated that STK33 can bind Bufalin. Notably, STK33 is highly expressed in TNBC and is associated with poor prognosis in TNBC patients. STK33 knockdown inhibits TNBC cell growth both in vitro and in vivo. Mechanistically, STK33 phosphorylates and stabilizes CCAR1, which promotes tumor growth and metastasis, thereby driving tumor progression. Further analyses confirmed that Methionine 245 of STK33 is required for STK33-Bufalin interaction, and Bufalin treatment promotes the degradation of STK33 protein by destroying the STK33-HSP90 complex. Through in vitro, in vivo, and in patient-derived TNBC organoids, it is observed that Bufalin inhibited the TNBC cell proliferation by targeting STK33. This study not only establishes Bufalin as a putative STK33 degrader to suppress TNBC but also identifies STK33 as a pro-cancer factor in TNBC, presenting a potential therapeutic target for TNBC.

Oxidative Medicine and Cellular Longevity IF:7.31 Authors:Xiaosheng Li, Shuoqi Li, Zhengwu Zang, Yinhao He Authors:Qiying Xie, Ziting Xie, Qiong Liu, Yixia Zhao, Nabeel M. Abdo, Hong Qi

Macrophage M2 polarization plays a pivotal role in breast cancer development. The present study aimed to investigate the interplay of the Leupaxin (LPXN)/HDAC6/EGR2 axis in breast cancer and its impact on macrophage M2 polarization. Our findings indicate that LPXN overexpression in breast cancer tissues correlates with M2 macrophage polarization. To investigate LPXN's potential role, we conducted siRNA-mediated silencing in macrophages. In a breast cancer cell-macrophage co-culture system, LPXN silencing was associated with reduced cancer cell proliferation, decreased M2 polarization markers, and diminished HDAC6 expression. BIOGRD and experimental data suggest a regulatory relationship between LPXN and HDAC6. Notably, HDAC6 inhibition partially reversed the pro-M2 effects of LPXN overexpression. Further mechanistic studies revealed that HDAC6 interacts with EGR2, functioning as its deacetylase and negatively regulating EGR2 expression. EGR2 silencing partially attenuated the anti-M2 effects observed with LPXN knockdown. In murine breast cancer models, LPXN silencing was linked to increased M1 macrophage markers and reduced tumor burden. These findings suggest LPXN may influence breast cancer progression through HDAC6/EGR2-mediated regulation of macrophage polarization. In conclusion, our study demonstrated that the LPXN/HDAC6/EGR2 axis promotes breast cancer progression by augmenting macrophage M2 polarization. Graphical

Authors:He Shaozhong, Wang Qun, He Jiayi, Chen Zhongyong, Xiao Yumei AMERICAN JOURNAL OF CHINESE MEDICINE IF:5.7 Authors:Zhiyuan Hao, Zheyu Zhang, Yuhang Zhao, Dongsheng Wang Authors:Wenjun Zhao, Yuwei Zhang, Weijie Li, Quanzhi Hu, Haozhang Huang, Xian Xu, Bing Du, Pan Li

This study aimed to elucidate the underlying mechanisms regarding microRNA-708-5p (miR-708-5p) in lung adenocarcinoma (LUAD). Here, the co-culture system of LUAD cells and macrophages, as well as a xenograft mouse model, were established. High levels of miR-708-5p were observed in LUAD. Exosomal miR-708-5p facilitated M2-like phenotype polarization, whereas miR-708-5p inhibition blocked the polarization. Exosomal miR-708-5p was identified as a pivotal signaling molecule for macrophages to mediate tumor cell proliferation, invasion, migration and IFN-γ production in T cells. In addition, miR708-5p was observed to induce PD-L1 expression, and PD-L1 silencing inhibited macrophage-induced tumor cell growth behavior and regulated CD8 T cell activity. In xenograft models, miR-708-5p inhibition and PD-L1 silencing attenuated macrophage-induced tumor growth, induced IFN-γ secretion and CD8 expression, and modulated the PTEN/AKT/mTOR pathway. In LUAD patients, there was an upregulation of both miR-708-5p and PD-L1 expression, accompanied by the activation of PTEN/AKT/mTOR. In conclusion, this study demonstrated the induction of M2 macrophage polarization and PD-L1 expression by exosomal miR-708-5p. We observed that exosomal miR-708-5p mediated the PTEN/AKT/mTOR pathway, diminished CD8 T cell activity and accelerated LUAD progression. The inhibition of specific exosomal miRNA secretion and anti-PD-L1 in the LUAD microenvironment may represent a promising avenue for LUAD immunotherapy.

Authors:Li Xu, Kang Li, Jia Li, Fang Xu, Shuzhi Liang, Yi Kong, Bolin Chen

相关资料下载:说明书(.pdf)(点击从官网下载)

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

ApplicationsIF 1:100-1:1000 FCM 1:100-1:1000
相关下载PDF下载 说明书下载 COA文档下载
货号AWS0006
应用IF,FCM
反应性Rabbit
来源Goat
Product DetailsHost Species:Goat
Reactivity:RabbitConcentration:1 mg/mL

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2016 年
所在地
湖南
收录条目
498 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

艾碧维 原厂
Abiowell

进入企业主页
498 本目录条目
产地 / 总部湖南省长沙高新区
成立年份2016 年
本目录主营蛋白与抗体 / 生化试剂 / 细胞生物学 / 分子生物学

公司产品涵盖抗体、细胞、培养基、质粒载体等多个领域,致力于为生命科学研究提供可靠的工具与解决方案。自创立以来,艾碧维始终秉持“求实、诚挚、勤勉、克己”的发展理念,坚持以自主研发与持续创新为核心动力。公司拥有百余人的团队,其中硕士及以上学历生物医学专业人才占比超过30%,包括博士4人,构建起一支结构合理、专业扎实的研发与服务队伍。通过设立研发部、生产部、市场与营销部、财务部等多功能部门,公司实现了从产品开发到市场推广的全流程管控。艾碧维不仅敢于质疑现状,积极为生命科学家突破技术壁垒提供支撑,更注重与客户的深度互动与合作,通过持续收集反馈、开展研发协作,提前预见并解决潜在问题。未来,公司将继续秉持“助力科研创新,让实验更简单”的使命,一步一个脚印地打造具有国际领先水平的技术研发与产业化平台,为全球生命科学领域的进步持续赋能。注意: 1.本公司产品仅供科研使用。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-10-31
科研在线(TeleVM). Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 594(AWS0006)[EB/OL]. 产品目录, 2026-10-31. https://www.suprotek.cn/products/item/goat-anti-rabbit-igg-h-l-secondary-antibody-alexa-fluor-594.html.
TeleVM. (2026, October 31). Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 594(AWS0006). 产品目录. https://www.suprotek.cn/products/item/goat-anti-rabbit-igg-h-l-secondary-antibody-alexa-fluor-594.html
@misc{biocsp_item_goat_anti_rabbit_igg_h_l_secondary_antibody_alexa_fluor_594,
  title        = {Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 594(AWS0006)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-10-31,产品目录},
  url          = {https://www.suprotek.cn/products/item/goat-anti-rabbit-igg-h-l-secondary-antibody-alexa-fluor-594.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 594

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。